Amylin Pharmaceuticals Shares Popped: What You Need to Know

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Amylin Pharmaceuticals (Nasdaq: AMLN  ) shares bounced 10% today on an upgrade from analysts at Leerink Swann.

So what: Amylin saw its stock drop 50% last week when regulators declined to approve Bydureon. The stock may have oversold on that news, and analysts think it still has upside even with a longer lead time on the diabetes treatment.

Now what: Bydureon still has a long road ahead and this Fool never likes buying because an analyst says so. This looks like a typical upgrade bump to me, without any solid news from the company. I'm selling the move today given the long-term uncertainty surrounding Bydureon.

Interested in more info on Amylin Pharmaceuticals? Add it to your watchlist here by clicking here.

Fool contributor Travis Hoium does not have a position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings or follow his CAPS picks at TMFFlushDraw.

Try any of our Foolish newsletter services free for 30 days. True to its name, The Motley Fool is made up of a motley assortment of writers and analysts, each with a unique perspective; sometimes we agree, sometimes we disagree, but we all believe in the power of learning from each other through our Foolish community. The Motley Fool has a disclosure policy.

Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 27, 2010, at 3:11 PM, sidinsd wrote:

    In your disclaimer you say that the writer holds no positions in any of the stocks mentioned, but the writer says "I'm selling the move today given the long-term uncertainty surrounding Bydureon". If he holds no positions, what ios he selling? Air? This is the kind of misleading stuff from tout services like yourselves that annoys the ?%%! out of me.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1347010, ~/Articles/ArticleHandler.aspx, 10/25/2016 11:58:04 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,193.24 -29.79 -0.16%
S&P 500 2,145.68 -5.65 -0.26%
NASD 5,291.47 -18.36 -0.35%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
AMLN.DL $0.00 Down +0.00 +0.00%
Amylin Pharmaceuti… CAPS Rating: **